Skip to Content
Merck
  • Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function.

Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function.

Cell stem cell (2020-10-23)
Kevin C Allan, Lucille R Hu, Marissa A Scavuzzo, Andrew R Morton, Artur S Gevorgyan, Erin F Cohn, Benjamin L L Clayton, Ilya R Bederman, Stevephen Hung, Cynthia F Bartels, Mayur Madhavan, Paul J Tesar
ABSTRACT

Mammalian cells respond to insufficient oxygen through transcriptional regulators called hypoxia-inducible factors (HIFs). Although transiently protective, prolonged HIF activity drives distinct pathological responses in different tissues. Using a model of chronic HIF1a accumulation in pluripotent-stem-cell-derived oligodendrocyte progenitors (OPCs), we demonstrate that HIF1a activates non-canonical targets to impair generation of oligodendrocytes from OPCs. HIF1a activated a unique set of genes in OPCs through interaction with the OPC-specific transcription factor OLIG2. Non-canonical targets, including Ascl2 and Dlx3, were sufficient to block differentiation through suppression of the oligodendrocyte regulator Sox10. Chemical screening revealed that inhibition of MEK/ERK signaling overcame the HIF1a-mediated block in oligodendrocyte generation by restoring Sox10 expression without affecting canonical HIF1a activity. MEK/ERK inhibition also drove oligodendrocyte formation in hypoxic regions of human oligocortical spheroids. This work defines mechanisms by which HIF1a impairs oligodendrocyte formation and establishes that cell-type-specific HIF1a targets perturb cell function in response to low oxygen.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
SB 431542 hydrate, ≥98% (HPLC), powder
Sigma-Aldrich
LDN193189 hydrochloride, ≥98% (HPLC)